Document is current

Any future updates will be listed below

Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy

Crossref DOI link: https://doi.org/10.1186/s13058-015-0524-0

Published Online: 2015-02-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark